Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-κB activation

Virology

Volumn 288, Issue 1, 2001, Pages 175-187

  Oie, Katrina L ^a   Pickup, David J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cowpox; Immunity; I B; Modified vaccinia Ankara; NF B; Pathogenesis; Poxvirus; TNF

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OKADAIC ACID; TUMOR NECROSIS FACTOR;

ARTICLE; COWPOX VIRUS; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; IMMUNITY; IMMUNOGENICITY; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANKARA; COWPOX VIRUS; ORTHOPOXVIRUS; POXVIRIDAE; RACCOONPOX VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0035884902     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1090     Document Type: Article

References (70)

1. Viral mechanisms of immune evasion
2. The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthepexviruses
3. Tissue factor expression in vital organs during murine traumatic shock: Role of transcription factors AP-1 and NF-κB
4. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
5. The transcription factor NF-κB and human disease
6. The NF-κB and IκB proteins: New discoveries and insights
7. 1 transition in mouse fibroblasts
8. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
9. Immunomodulatory proteins of myxoma virus
10. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein
11. Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
12. The role of nuclear factor-κB in cytokine gene regulation
13. Vaccinia virus 19-kilodalton protein: Relationship to several mammalian proteins, including two growth factors
14. Role of NFκB in the mortality of sepsis
15. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
16. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor
17. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line
18. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model
19. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
20. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases
21. Nuclear factor κB: A pivotal role in the systemic inflammatory response syndrome and new target for therapy
22. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
23. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2
24. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
25. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
26. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells
27. Variola virus and other orthopoxviruses
28. The clinical features of smallpox
29. NF-κB to the rescue: RELs, apoptosis and cellular transformation
30. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
31. The complete DNA sequence of vaccinia virus
32. A tyr/ser protein phosphatase encoded by vaccinia virus
33. A protein phosphatase related to the vaccinia virus VH1 is encoded in the genomes of several orthoposviruses and a baculovirus
34. Hostile takeovers: Viral appropriation of the NF-κB pathway
35. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family
36. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor
37. Phosphorylation meets ubiquitination: The control of NF-κB activity
38. Role of DNA replication in vaccinia virus gene expression: A naked template is required for transcription of three late trans-activator genes
39. Smallpox: Clinical types, causes of death, and treatment
40. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB
41. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer
42. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
43. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro
44. A third distinct tumor necrosis factor receptor of orthopoxviruses
45. Potential virulence determinants in terminal regions of variola smallpox virus genome
46. NF-κB in neuronal plasticity and neurodegenerative disorders
47. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
48. Immunology 101 at poxvirus U: Immune evasion genes
49. Vaccinia virus blocks gamma interferon signal transduction: Viral VH1 phosphatase reverses Stat1 activation
50. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination
51. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: Virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine
52. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the intedeukin-1 β converting enzyme
53. Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment
54. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses
55. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
56. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase
57. Entire coding sequence of the variola virus
58. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
59. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor
60. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha
61. Vaccinia virus immune evasion
62. Nucleotide Sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat
63. One step ahead of the game: Viral immunomodulatory molecules
64. Epidermal growth factor activation of NF-κB is mediated through IκBα degradation and intracellular free calcium
65. Activation of NF-κB by phosphatase inhibitors involves the phosphorylation of IκBα at phosphatase 2A-sensitive sites
66. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
67. Viral subversion of the immune system
68. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
69. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors
70. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation